During the past decade, MVZ Nordhausen conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MVZ Nordhausen" #1 collaborator was "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "MVZ Nordhausen" are "Recurrent Ovarian Carcinoma" (2 trials), "Fallopian Tube Cancer" (1 trials), "Ovarian Cancer" (1 trials), "Peritoneal Cancer" (1 trials) and "Recurrent Platinum-sensitive Ovarian Cancer" (1 trials). Many other conditions were trialed in "MVZ Nordhausen" in a lesser frequency.

Most popular intervention types in "MVZ Nordhausen" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "Atezolizumab" (2 trials), "Niraparib" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "MVZ Nordhausen" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "MVZ Nordhausen". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MVZ Nordhausen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MVZ Nordhausen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".